申请人:Merrell Dow Pharmaceuticals Inc.
公开号:US04621145A1
公开(公告)日:1986-11-04
4-Amino-5-hexenoic acid is prepared by: (a) reacting 5-oxo-2-pyrrolidine-acetonitrile with hydrogen and dimethylamine in the presence of a palladium catalyst to form N,N-dimethyl-2-[5'-oxo-2'-pyrrolidine]ethylamine; (b) oxidizing N,N-dimethyl-2-[5'-oxo-2'-pyrrolidine]-ethylamine to produce the corresponding N-oxide derivative; (c) pyrolysis of the N-oxide derivative to form 5-vinyl-2-pyrrolidinone; (d) optionally, separating N,N-dimethyl-2-[5'-oxo-2'-pyrrolidine]ethylamine by-product from the 5-vinyl-2-pyrrolidinone product; and (e) hydrolyzing 5-vinyl-2-pyrrolidinone to form 4-amino-5-hexenoic acid.
4-氨基-5-己烯酸的制备方法为:(a)将5-氧代-2-吡咯烷-乙腈与氢气和二甲胺在钯催化剂存在下反应,形成N,N-二甲基-2-[5'-氧代-2'-吡咯烷]乙胺;(b)将N,N-二甲基-2-[5'-氧代-2'-吡咯烷]乙胺氧化,得到相应的N-氧化物衍生物;(c)对N-氧化物衍生物进行热解,形成5-乙烯基-2-吡咯酮;(d)可选地,将N,N-二甲基-2-[5'-氧代-2'-吡咯烷]乙胺副产物与5-乙烯基-2-吡咯酮产品分离;(e)对5-乙烯基-2-吡咯酮进行水解,形成4-氨基-5-己烯酸。